OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological insights in non-small cell lung cancer
Rafael Rosell, Anisha Jain, Jordi Codony‐Servat, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 17

Showing 17 citing articles:

5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer
Youming Chen, Zuli Jiang, Chenxing Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 106793-106793
Open Access | Times Cited: 13

KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
Linyan Tian, Chengming Liu, Sufei Zheng, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Integrative Bioinformatics Analysis of Pyroptosis-Related Genes and Analysis of Immune Cell Infiltration in Infantile Hemangioma Regression
Lan Liu, Sheng Lin, Jianxi Bai, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 291-302
Open Access

Ferroptosis: mechanisms and therapeutic targets
Qian Zhou, Yu Meng, Jiayuan Le, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4

Metabolomics and lipidomics in non-small cell lung cancer
Wei Shi, Yizhen Cheng, Haihua Zhu, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117823-117823
Closed Access | Times Cited: 4

Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies
Yongyi Liang, Shaojun Qiu, Youwen Zou, et al.
Phytomedicine (2023) Vol. 122, pp. 155134-155134
Closed Access | Times Cited: 9

Targeting ferroptosis regulators in lung cancer: Exploring natural products
Yuhao Wang, Cheng Shenghua, Chen Jueying, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e33934-e33934
Open Access | Times Cited: 1

Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis
Gengwei Huo, Ying Song, Xiongwen Chen, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 4, pp. 839-848
Open Access

Lanatoside C induces ferroptosis in non-small cell lung cancer in vivo and in vitro by regulating SLC7A11/GPX4 signaling pathway
Yaozong Xia, Teng Liu, Shi‐hua Deng, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2295-2307
Open Access

Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC
Fushi Han, Shuzhen Chen, Kangwei Zhang, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access

Pyroptosis and chemical classification of pyroptotic agents
Mohammed A Hara, Mohamed Ramadan, Mohammed K. Abdelhameid, et al.
Molecular Diversity (2024)
Open Access

Different treatment modalities on the prognosis of patients with stage I–IIIa small cell lung cancer: a population based study
Fangjun Chen, Zihan Wang, Xing Gu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 5, pp. 2822-2834
Open Access

GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies
Hirotomo Takahara, T Kanazawa, Hiroo OSHITA, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3888-3888
Open Access

Decoding ferroptosis: transforming orthopedic disease management
Guochen Huo, Yumeng Lin, Lusheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Page 1

Scroll to top